NICE has backed NHS use of natalizumab, a key treatment option that is safe for use in pregnancy, for more patients with multiple sclerosis. NICE has said Biogen's Tysabri can now be used by the NHS ...
AppLovin posted 66% YoY revenue growth and 84% EBITDA margin in Q4 ’25, while reducing marketing and R&D expenses. Find out ...
Introducing Shadcn's innovative visual project builder, accessible via `npx shadcn create`. This tool empowers developers to customize project setups visually before coding, ensuring a seamless design ...
Microsoft has today announced the first Australian customers to access Microsoft 365 Copilot as part of the invitation-only global Early Access Program (EAP). AGL, Data#3, Bupa, NAB, Powerlink ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results